Orthopaedic gene therapy using recombinant adeno-associated virus vectors.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Archives of Oral Biology

• Publication date

  2011-07-01

• Fields of study

  Biology, Medicine, Engineering

• Identifiers
  DOI 10.1016/j.archoralbio.2010.12.010PMID 21354554
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• AAV5-mediated gene transfer to the parotid glands of non-human primates

  2010cited by this paper
• Freeze-dried tendon allografts as tissue-engineering scaffolds for Gdf5 gene delivery.

  2008cited by this paper
• Adeno-associated virus-2-mediated bFGF gene transfer to digital flexor tendons significantly increases healing strength. an in vivo study.

  2008cited by this paper
• Gene targeting of mutant COL1A2 alleles in mesenchymal stem cells from individuals with osteogenesis imperfecta.

  2008cited by this paper
• Systemic AAV-9 transduction in mice is influenced by animal age but not by the route of administration

  2007cited by this paper
• Adeno-Associated Virus Type 12 (AAV12): a Novel AAV Serotype with Sialic Acid- and Heparan Sulfate Proteoglycan-Independent Transduction Activity

  2007cited by this paper
• Recombinant AAV-mediated VEGF gene therapy induces mandibular condylar growth

  2007cited by this paper
• Direct AAV-mediated gene delivery to the temporomandibular joint.

  2007cited by this paper
• Adeno-associated viral gene transfer of transforming growth factor-β1 to human mesenchymal stem cells improves cartilage repair

  2007cited by this paper
• Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products

  2007cited by this paper
• Tendon Healing In Vitro: Adeno-Associated Virus-2 Effectively Transduces Intrasynovial Tenocytes with Persistent Expression of the Transgene, but Other Serotypes Do Not

  2007cited by this paper
• The use of recombinant adeno-associated virus for skeletal gene therapy.

  2007cited by this paper
• Different Osteogenic Potentials of Recombinant Human BMP-6 Adeno-Associated Virus and Adenovirus in Two Rat Strains

  2006cited by this paper
• Enhanced transduction of mouse salivary glands with AAV5-based vectors

  2006cited by this paper
• Tissue reactions of adenoviral, adeno-associated viral, and liposome-plasmid vectors in tendons and comparison with early-stage healing responses of injured flexor tendons.

  2006cited by this paper
• Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy

  2005cited by this paper
• Dual transduction of insulin‐like growth factor‐I and interleukin‐l receptor antagonist protein controls cartilage degradation in an osteoarthritic culture model

  2005cited by this paper
• Localized gene expression following administration of adeno-associated viral vectors via pancreatic ducts.

  2005cited by this paper
• Determination of osteoprogenitor-specific promoter activity in mouse mesenchymal stem cells by recombinant adeno-associated virus transduction

  2005cited by this paper
• Biological effects of rAAV-caAlk2 coating on structural allograft healing.

  2005cited by this paper
• Gene-mediated restoration of cartilage matrix by combination insulin-like growth factor-I/interleukin-1 receptor antagonist therapy

  2005cited by this paper
• Repair of Articular Cartilage Defect by Intraarticular Administration of Basic Fibroblast Growth Factor Gene, Using Adeno-Associated Virus Vector

  2005cited by this paper
• Structure of Adeno-Associated Virus Type 4

  2005cited by this paper
• Adeno-Associated Virus Pseudotype 5 Vector Improves Gene Transfer in Arthritic Joints

  2005cited by this paper
• Repair of articular cartilage defect by autologous transplantation of basic fibroblast growth factor gene-transduced chondrocytes with adeno-associated virus vector.

  2005cited by this paper
• Adeno-associated virus-mediated bone morphogenetic protein-7 gene transfer induces C2C12 cell differentiation into osteoblast lineage cells

  2005cited by this paper
• Improved tissue repair in articular cartilage defects in vivo by rAAV-mediated overexpression of human fibroblast growth factor 2.

  2005cited by this paper
• Gene therapy with human osteoprotegerin decreases callus remodeling with limited effects on biomechanical properties.

  2005cited by this paper
• Adeno-Associated Virus Types 5 and 6 Use Distinct Receptors for Cell Entry

  2005cited by this paper
• New recombinant serotypes of AAV vectors.

  2005cited by this paper
• Comparison of Adenoviral and Adeno-Associated Viral Vectors for Pancreatic Gene Delivery In Vivo

  2004cited by this paper
• Determination of osteoprogenitor-specific promoter activity in mouse mesenchymal stem cells by recombinant adeno-associated virus transduction.

  2004cited by this paper
• Osteogenic Differentiation of Recombinant Adeno-Associated Virus 2-Transduced Murine Mesenchymal Stem Cells and Development of an Immunocompetent Mouse Model for Ex Vivo Osteoporosis Gene Therapy

  2004cited by this paper
• Gene therapy platform for bone regeneration using an exogenously regulated, AAV-2-based gene expression system.

  2004cited by this paper
• Two novel adeno-associated viruses from cynomolgus monkey: pseudotyping characterization of capsid protein.

  2004cited by this paper
• Combination of adeno-associated virus and adenovirus vectors expressing bone morphogenetic protein-2 produces enhanced osteogenic activity in immunocompetent rats.

  2004cited by this paper
• Gene Targeting in Stem Cells from Individuals with Osteogenesis Imperfecta

  2004cited by this paper
• Menisci are Efficiently Transduced by Recombinant Adeno-Associated virus Vectors in Vitro and in Vivo

  2004cited by this paper
• Gene therapy with human recombinant osteoprotegerin reverses established osteopenia in ovariectomized mice.

  2004cited by this paper
• Recombinant Adeno-Associated Virus Vectors Efficiently and Persistently Transduce Chondrocytes in Normal and Osteoarthritic Human Articular Cartilage

  2003cited by this paper
• Generation and characterization of chimeric recombinant AAV vectors.

  2003cited by this paper
• From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy.

  2003cited by this paper
• Gene therapy for new bone formation using adeno-associated viral bone morphogenetic protein-2 vectors

  2003cited by this paper
• Adeno-associated virus-mediated bone morphogenetic protein-4 gene therapy for in vivo bone formation.

  2003cited by this paper
• Targeting recombinant adeno-associated virus vectors to enhance gene transfer to pancreatic islets and liver

  2003cited by this paper
• Genetic Fate of Recombinant Adeno-Associated Virus Vector Genomes in Muscle

  2003cited by this paper
• Light-activated gene transduction enhances adeno-associated virus vector-mediated gene expression in human articular chondrocytes.

  2002cited by this paper
• Expression of human factor VIII by splicing between dimerized AAV vectors.

  2002cited by this paper
• Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

  2002cited by this paper
• Tetracycline-Inducible Interleukin-10 Gene Transfer Mediated by an Adeno-Associated Virus: Application to Experimental Arthritis

  2002cited by this paper
• Recombinant Adeno-Associated Virus-Mediated Osteoprotegerin Gene Therapy Inhibits Wear Debris-Induced Osteolysis

  2002cited by this paper
• Conjugate-Based Targeting of Recombinant Adeno-Associated Virus Type 2 Vectors by Using Avidin-Linked Ligands

  2002cited by this paper
• Intraarticular gene transfer of TNFR:Fc suppresses experimental arthritis with reduced systemic distribution of the gene product.

  2002cited by this paper
• Adenovirus and Adeno-Associated Virus Vectors

  2002cited by this paper
• Structural Changes in the Forefoot of Individuals with Diabetes and a Prior Plantar Ulcer

  2002cited by this paper
• Ubiquitination of both Adeno-Associated Virus Type 2 and 5 Capsid Proteins Affects the Transduction Efficiency of Recombinant Vectors

  2002cited by this paper
• Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model.

  2001cited by this paper
• Expanding AAV packaging capacity with trans-splicing or overlapping vectors: a quantitative comparison.

  2001cited by this paper
• Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells.

  2001cited by this paper
• Hybrid Vectors Based on Adeno-Associated Virus Serotypes 2 and 5 for Muscle-Directed Gene Transfer

  2001cited by this paper
• Extrachromosomal Recombinant Adeno-Associated Virus Vector Genomes Are Primarily Responsible for Stable Liver Transduction In Vivo

  2001cited by this paper
• Adeno-Associated Virus Type 6 (AAV6) Vectors Mediate Efficient Transduction of Airway Epithelial Cells in Mouse Lungs Compared to That of AAV2 Vectors

  2001cited by this paper
• Infection of purified nuclei by adeno-associated virus 2.

  2001cited by this paper
• Therapy and prevention of arthritis by recombinant adeno-associated virus vector with delivery of interleukin-1 receptor antagonist.

  2000cited by this paper
• The Use of Adeno-Associated Virus to Circumvent the Maturation-Dependent Viral Transduction of Muscle Fibers

  2000cited by this paper
• Gene delivery to human chondrocytes by an adeno associated virus vector.

  2000cited by this paper
• Endocytosis and Nuclear Trafficking of Adeno-Associated Virus Type 2 Are Controlled by Rac1 and Phosphatidylinositol-3 Kinase Activation

  2000cited by this paper
• Adeno-associated virus mediates long-term gene transfer and delivery of chondroprotective IL-4 to murine synovium.

  2000cited by this paper
• Humoral Immunity to Adeno-Associated Virus Type 2 Vectors following Administration to Murine and Nonhuman Primate Muscle

  2000cited by this paper
• Adeno-Associated Virus Production of Soluble Tumor Necrosis Factor Receptor Neutralizes Tumor Necrosis Factor α and Reduces Arthritis

  2000cited by this paper
• Adeno-associated virus production of soluble tumor necrosis factor receptor neutralizes tumor necrosis factor alpha and reduces arthritis.

  2000cited by this paper
• Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus.

  2000cited by this paper
• Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system.

  2000cited by this paper
• Empirical advantages of adeno associated viral vectors in vivo gene therapy for arthritis.

  2000cited by this paper
• AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection.

  1999cited by this paper
• αVβ5 integrin: a co-receptor for adeno-associated virus type 2 infection

  1999cited by this paper
• Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield

  1999cited by this paper
• Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab'γ)2 antibody

  1999cited by this paper
• Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2

  1999cited by this paper
• Gene Therapy Vectors Based on Adeno-Associated Virus Type 1

  1999cited by this paper
• Immune responses to adenovirus and adeno-associated virus in humans

  1999cited by this paper
• High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap

  1999cited by this paper
• Latent Adeno-Associated Virus Infection Elicits Humoral but Not Cell-Mediated Immune Responses in a Nonhuman Primate Model

  1999cited by this paper
• Membrane-Associated Heparan Sulfate Proteoglycan Is a Receptor for Adeno-Associated Virus Type 2 Virions

  1998cited by this paper
• The kinetics of rAAV integration in the liver

  1998cited by this paper
• Infectious Clones and Vectors Derived from Adeno-Associated Virus (AAV) Serotypes Other Than AAV Type 2

  1998cited by this paper
• New developments in the generation of Ad-free, high-titer rAAV gene therapy vectors

  1997cited by this paper
• Recombinant adeno-associated virus for muscle directed gene therapy

  1997cited by this paper
• Adeno-associated virus vector integration junctions

  1997cited by this paper
• Adeno-associated virus Rep proteins target DNA sequences to a unique locus in the human genome

  1997cited by this paper
• The cryptic life style of adenoassociated virus

  1995cited by this paper
• DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors.

  1995cited by this paper
• DNA-damaging agents greatly increase the transduction of nondividing cells by adeno-associated virus vectors

  1994cited by this paper
• Replication of adeno-associated virus in cells irradiated with UV light at 254 nm

  1989cited by this paper
• Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression

  1989cited by this paper
• Nucleotide sequence and organization of the adeno-associated virus 2 genome

  1983cited by this paper
• Adeno-associated viruses.

  1979cited by this paper
• Adenovirus associated viruses.

  1970cited by this paper

• Biomechanical characteristics of frozen bone allografts after gene therapy-induced revascularization.

  2025cites this paper
• Vasculogenic gene therapy: No role for revitalization of structural bone allografts

  2022cites this paper
• Genetic modification of mesenchymal stem cells to enhance their anti-tumor efficacy

  2021cites this paper
• Vascular Tumors Result from Adeno-Associated Virus-9 Angiogenic Gene Therapy of Bone Allografts

  2020cites this paper
• Limited potential of AAV-mediated gene therapy in transducing human mesenchymal stem cells for bone repair applications

  2020cites this paper
• The study of genes and signal transduction pathways involved in mustard lung injury: A gene therapy approach.

  2019cites this paper
• Intra-luminal gene therapy in the porcine artery using a recombinant adeno-associated virus 9.

  2017influential citation
• Gene Delivery Approaches for Mesenchymal Stem Cell Therapy: Strategies to Increase Efficiency and Specificity

  2017cites this paper
• A comprehensive review of gene therapy, recent progress and future prospects n

  2016cites this paper
• Adeno associated viral vectors for brain gene therapy

  2015cites this paper
• [Advances in the application of gene therapy for Parkinson's disease with adeno-associated virus].

  2014cites this paper
• Recent progresses in gene delivery-based bone tissue engineering.

  2013influential citation
• Genetic modification of mesenchymal stem cells in spinal cord injury repair strategies.

  2013cites this paper
• Bone repair cells for craniofacial regeneration.

  2012cites this paper